GLOBAL IMMUNE THROMBOCYTOPENIA DRUGS MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Nov 2019 108
Table of Contents

1 Immune Thrombocytopenia Drugs Market Overview
1.1 Product Overview and Scope of Immune Thrombocytopenia Drugs
1.2 Classification of Immune Thrombocytopenia Drugs by Types
1.2.1 Global Immune Thrombocytopenia Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Immune Thrombocytopenia Drugs Revenue Market Share by Types in 2018
1.2.3 Thrombopoietin Receptor Agonists (TPO-RAs)
1.2.4 Corticosteroids
1.2.5 Intravenous Immunoglobins (IVIGs)
1.2.6 Other Drugs
1.3 Global Immune Thrombocytopenia Drugs Market by Application
1.3.1 Global Immune Thrombocytopenia Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Hospitals and Diagnostic Centers
1.3.4 Academic Institutes and Research Organizations
1.4 Global Immune Thrombocytopenia Drugs Market by Regions
1.4.1 Global Immune Thrombocytopenia Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Immune Thrombocytopenia Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Immune Thrombocytopenia Drugs (2014-2024)
2 Company Profiles
2.1 Amgen Inc.
2.1.1 Business Overview
2.1.2 Immune Thrombocytopenia Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Merck & Co., Inc.
2.2.1 Business Overview
2.2.2 Immune Thrombocytopenia Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck & Co., Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 CSL Ltd.
2.3.1 Business Overview
2.3.2 Immune Thrombocytopenia Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Ltd. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Horizon Therapeutics Plc
2.4.1 Business Overview
2.4.2 Immune Thrombocytopenia Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Rigel Pharmaceuticals Inc.
2.5.1 Business Overview
2.5.2 Immune Thrombocytopenia Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Novartis AG
2.6.1 Business Overview
2.6.2 Immune Thrombocytopenia Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis AG Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Immune Thrombocytopenia Drugs Market Competition, by Players
3.1 Global Immune Thrombocytopenia Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Immune Thrombocytopenia Drugs Players Market Share
3.2.2 Top 10 Immune Thrombocytopenia Drugs Players Market Share
3.3 Market Competition Trend
4 Global Immune Thrombocytopenia Drugs Market Size by Regions
4.1 Global Immune Thrombocytopenia Drugs Revenue and Market Share by Regions
4.2 North America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
5 North America Immune Thrombocytopenia Drugs Revenue by Countries
5.1 North America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
5.2 USA Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6 Europe Immune Thrombocytopenia Drugs Revenue by Countries
6.1 Europe Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
6.2 Germany Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.4 France Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Immune Thrombocytopenia Drugs Revenue by Countries
7.1 Asia-Pacific Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
7.2 China Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.5 India Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
8 South America Immune Thrombocytopenia Drugs Revenue by Countries
8.1 South America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
8.2 Brazil Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Immune Thrombocytopenia Drugs by Countries
9.1 Middle East and Africa Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
10 Global Immune Thrombocytopenia Drugs Market Segment by Type
10.1 Global Immune Thrombocytopenia Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Immune Thrombocytopenia Drugs Market Forecast by Type (2019-2024)
10.3 Thrombopoietin Receptor Agonists (TPO-RAs) Revenue Growth Rate (2014-2024)
10.4 Corticosteroids Revenue Growth Rate (2014-2024)
10.5 Intravenous Immunoglobins (IVIGs) Revenue Growth Rate (2014-2024)
10.6 Other Drugs Revenue Growth Rate (2014-2024)
11 Global Immune Thrombocytopenia Drugs Market Segment by Application
11.1 Global Immune Thrombocytopenia Drugs Revenue Market Share by Application (2014-2019)
11.2 Immune Thrombocytopenia Drugs Market Forecast by Application (2019-2024)
11.3 Biotechnology and Pharmaceutical Companies Revenue Growth (2014-2019)
11.4 Hospitals and Diagnostic Centers Revenue Growth (2014-2019)
11.5 Academic Institutes and Research Organizations Revenue Growth (2014-2019)
12 Global Immune Thrombocytopenia Drugs Market Size Forecast (2019-2024)
12.1 Global Immune Thrombocytopenia Drugs Market Size Forecast (2019-2024)
12.2 Global Immune Thrombocytopenia Drugs Market Forecast by Regions (2019-2024)
12.3 North America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.6 South America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Immune Thrombocytopenia Drugs Picture
Table Product Specifications of Immune Thrombocytopenia Drugs
Table Global Immune Thrombocytopenia Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Types in 2018
Figure Thrombopoietin Receptor Agonists (TPO-RAs) Picture
Figure Corticosteroids Picture
Figure Intravenous Immunoglobins (IVIGs) Picture
Figure Other Drugs Picture
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Application (2014-2024)
Figure Immune Thrombocytopenia Drugs Revenue Market Share by Applications in 2018
Figure Biotechnology and Pharmaceutical Companies Picture
Figure Hospitals and Diagnostic Centers Picture
Figure Academic Institutes and Research Organizations Picture
Table Global Market Immune Thrombocytopenia Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen Inc. Immune Thrombocytopenia Drugs Type and Applications
Table Amgen Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Immune Thrombocytopenia Drugs Type and Applications
Table Merck & Co., Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Ltd. Basic Information, Manufacturing Base and Competitors
Table CSL Ltd. Immune Thrombocytopenia Drugs Type and Applications
Table CSL Ltd. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Horizon Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Type and Applications
Table Horizon Therapeutics Plc Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Rigel Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Type and Applications
Table Rigel Pharmaceuticals Inc. Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Immune Thrombocytopenia Drugs Type and Applications
Table Novartis AG Immune Thrombocytopenia Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Share by Players (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Players in 2017
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Immune Thrombocytopenia Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Immune Thrombocytopenia Drugs Revenue Market Share in 2018
Figure Global Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Regions in 2018
Figure North America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure South America Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table North America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
Table North America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure USA Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Europe Immune Thrombocytopenia Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure Germany Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure UK Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure France Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Immune Thrombocytopenia Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure China Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure India Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table South America Immune Thrombocytopenia Drugs Revenue by Countries (2014-2019)
Table South America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure Brazil Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Immune Thrombocytopenia Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Immune Thrombocytopenia Drugs Revenue and Growth Rate (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Share by Type (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Type (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Type in 2018
Table Global Immune Thrombocytopenia Drugs Revenue Forecast by Type (2019-2024)
Figure Global Immune Thrombocytopenia Drugs Market Share Forecast by Type (2019-2024)
Figure Global Thrombopoietin Receptor Agonists (TPO-RAs) Revenue Growth Rate (2014-2019)
Figure Global Corticosteroids Revenue Growth Rate (2014-2019)
Figure Global Intravenous Immunoglobins (IVIGs) Revenue Growth Rate (2014-2019)
Figure Global Other Drugs Revenue Growth Rate (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue by Application (2014-2019)
Table Global Immune Thrombocytopenia Drugs Revenue Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Share by Application in 2018
Table Global Immune Thrombocytopenia Drugs Revenue Forecast by Application (2019-2024)
Figure Global Immune Thrombocytopenia Drugs Market Share Forecast by Application (2019-2024)
Figure Global Biotechnology and Pharmaceutical Companies Revenue Growth Rate (2014-2019)
Figure Global Hospitals and Diagnostic Centers Revenue Growth Rate (2014-2019)
Figure Global Academic Institutes and Research Organizations Revenue Growth Rate (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Immune Thrombocytopenia Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure Europe Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure South America Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Immune Thrombocytopenia Drugs Revenue Market Forecast (2019-2024)

Table of Contents

Related reports :

(Nov 19)

Scope of the Report: The worldwide market for Pulmonary Surfactant is expected to grow at a CAGR of roughly xx% over the next five ye...

(Nov 19)

Scope of the Report: The worldwide market for Denture Repair Material is expected to grow at a CAGR of roughly xx% over the next five...

(Nov 19)

Scope of the Report: The global Single Cell Multi-Omics market is valued at xx million USD in 2018 and is expected to reach xx millio...

(Nov 19)

Scope of the Report: The worldwide market for Parenteral Drugs is expected to grow at a CAGR of roughly xx% over the next five years,...

(Nov 19)

Scope of the Report: The global Dabigatran market is valued at xx million USD in 2018 and is expected to reach xx million USD by the ...

(Nov 19)

Scope of the Report: The worldwide market for Cannabis Concentrate is expected to grow at a CAGR of roughly xx% over the next five ye...

Global Info Research

GLOBAL IMMUNE THROMBOCYTOPENIA DRUGS MARKET 2019 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy